Cargando…

Considerations for the Full Global Withdrawal of Oral Polio Vaccine After Eradication of Polio

Eliminating the risk of polio from vaccine-derived polioviruses is essential for creating a polio-free world, and eliminating that risk will require stopping use of all oral polio vaccines (OPVs) once all types of wild polioviruses have been eradicated. In many ways, the experience with the global s...

Descripción completa

Detalles Bibliográficos
Autores principales: Hampton, Lee M., du Châtellier, Gaël Maufras, Fournier-Caruana, Jacqueline, Ottosen, Ann, Rubin, Jennifer, Menning, Lisa, Farrell, Margaret, Shendale, Stephanie, Patel, Manish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853572/
https://www.ncbi.nlm.nih.gov/pubmed/28838193
http://dx.doi.org/10.1093/infdis/jix105
_version_ 1783306777236865024
author Hampton, Lee M.
du Châtellier, Gaël Maufras
Fournier-Caruana, Jacqueline
Ottosen, Ann
Rubin, Jennifer
Menning, Lisa
Farrell, Margaret
Shendale, Stephanie
Patel, Manish
author_facet Hampton, Lee M.
du Châtellier, Gaël Maufras
Fournier-Caruana, Jacqueline
Ottosen, Ann
Rubin, Jennifer
Menning, Lisa
Farrell, Margaret
Shendale, Stephanie
Patel, Manish
author_sort Hampton, Lee M.
collection PubMed
description Eliminating the risk of polio from vaccine-derived polioviruses is essential for creating a polio-free world, and eliminating that risk will require stopping use of all oral polio vaccines (OPVs) once all types of wild polioviruses have been eradicated. In many ways, the experience with the global switch from trivalent OPV (tOPV) to bivalent OPV (bOPV) can inform the eventual full global withdrawal of OPV. Significant preparation will be needed for a thorough, synchronized, and full withdrawal of OPV, and such preparation would be aided by setting a reasonably firm date for OPV withdrawal as far in advance as possible, ideally at least 24 months. A shorter lead time would provide valuable flexibility for decisions about when to stop use of OPV in the context of uncertainty about whether or not all types of wild polioviruses had been eradicated, but it might increase the cost of OPV withdrawal.
format Online
Article
Text
id pubmed-5853572
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-58535722018-07-01 Considerations for the Full Global Withdrawal of Oral Polio Vaccine After Eradication of Polio Hampton, Lee M. du Châtellier, Gaël Maufras Fournier-Caruana, Jacqueline Ottosen, Ann Rubin, Jennifer Menning, Lisa Farrell, Margaret Shendale, Stephanie Patel, Manish J Infect Dis Supplement Article Eliminating the risk of polio from vaccine-derived polioviruses is essential for creating a polio-free world, and eliminating that risk will require stopping use of all oral polio vaccines (OPVs) once all types of wild polioviruses have been eradicated. In many ways, the experience with the global switch from trivalent OPV (tOPV) to bivalent OPV (bOPV) can inform the eventual full global withdrawal of OPV. Significant preparation will be needed for a thorough, synchronized, and full withdrawal of OPV, and such preparation would be aided by setting a reasonably firm date for OPV withdrawal as far in advance as possible, ideally at least 24 months. A shorter lead time would provide valuable flexibility for decisions about when to stop use of OPV in the context of uncertainty about whether or not all types of wild polioviruses had been eradicated, but it might increase the cost of OPV withdrawal. Oxford University Press 2017-07-01 2017-07-01 /pmc/articles/PMC5853572/ /pubmed/28838193 http://dx.doi.org/10.1093/infdis/jix105 Text en © The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. https://creativecommons.org/licenses/by/3.0/igo/ This is an Open Access article distributed under the terms of the Creative Commons Attribution 3.0 IGO (CC BY 3.0 IGO) License (https://creativecommons.org/licenses/by/3.0/igo/) which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Supplement Article
Hampton, Lee M.
du Châtellier, Gaël Maufras
Fournier-Caruana, Jacqueline
Ottosen, Ann
Rubin, Jennifer
Menning, Lisa
Farrell, Margaret
Shendale, Stephanie
Patel, Manish
Considerations for the Full Global Withdrawal of Oral Polio Vaccine After Eradication of Polio
title Considerations for the Full Global Withdrawal of Oral Polio Vaccine After Eradication of Polio
title_full Considerations for the Full Global Withdrawal of Oral Polio Vaccine After Eradication of Polio
title_fullStr Considerations for the Full Global Withdrawal of Oral Polio Vaccine After Eradication of Polio
title_full_unstemmed Considerations for the Full Global Withdrawal of Oral Polio Vaccine After Eradication of Polio
title_short Considerations for the Full Global Withdrawal of Oral Polio Vaccine After Eradication of Polio
title_sort considerations for the full global withdrawal of oral polio vaccine after eradication of polio
topic Supplement Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853572/
https://www.ncbi.nlm.nih.gov/pubmed/28838193
http://dx.doi.org/10.1093/infdis/jix105
work_keys_str_mv AT hamptonleem considerationsforthefullglobalwithdrawaloforalpoliovaccineaftereradicationofpolio
AT duchatelliergaelmaufras considerationsforthefullglobalwithdrawaloforalpoliovaccineaftereradicationofpolio
AT fourniercaruanajacqueline considerationsforthefullglobalwithdrawaloforalpoliovaccineaftereradicationofpolio
AT ottosenann considerationsforthefullglobalwithdrawaloforalpoliovaccineaftereradicationofpolio
AT rubinjennifer considerationsforthefullglobalwithdrawaloforalpoliovaccineaftereradicationofpolio
AT menninglisa considerationsforthefullglobalwithdrawaloforalpoliovaccineaftereradicationofpolio
AT farrellmargaret considerationsforthefullglobalwithdrawaloforalpoliovaccineaftereradicationofpolio
AT shendalestephanie considerationsforthefullglobalwithdrawaloforalpoliovaccineaftereradicationofpolio
AT patelmanish considerationsforthefullglobalwithdrawaloforalpoliovaccineaftereradicationofpolio